Table of Contents Table of Contents
Previous Page  815 860 Next Page
Information
Show Menu
Previous Page 815 860 Next Page
Page Background

1.

Introduction

Testicular GCT remains the most common solid organ

malignancy in young males, and its incidence has increased

over the past 20 yr

[1] .

With the current multimodal

treatment algorithms, overall survival rates exceed 95%

[2]

. This is largely attributable to the advent of cisplatin-

based therapy 40 yr ago, as well as refinement of surgical

indications and technique. The challenge in this young and

otherwise healthy patient population is minimization of

treatment morbidity, which must be viewed cumulatively

over many decades.

We previously described our novel approach to retro-

peritoneal lymph node dissection (RPLND) via a midline

incision that is completely extraperitoneal

[3]

. This ap-

proach was initiated as an attempt to minimize the

perioperative and long-term complications associated with

entering the peritoneal cavity, and we demonstrated in a

small initial series that it afforded faster return of bowel

function and shorter length of hospital stay (LOS) without

compromising exposure or the ability to complete a full

node dissection, even in the postchemotherapy (PC) setting.

Here we describe our updated series, review the specifics of

the technique, and report on our outcomes.

2.

Patients and methods

2.1.

Study population

All patients were from an institutional review board–approved testis

cancer database with prospectively collected data. From 2004 to 2015,

169 patients underwent RPLND (135 PC, 34 primary). As of 2010, all

patients were considered for EP-RPLND except for men undergoing

aortic resection, retrocrural dissection, or intraperitoneal resection

(exclusion criteria). Of the remaining 122, some 69 consecutive patients

underwent EP-RPLND using a midline incision; one patient was

converted to transperitoneal (TP) RPLND because of failure to progress

( Table 1

). Primary cases underwent extended ipsilateral templates; PC

cases underwent either full bilateral or extended ipsilateral templates

according to validated criteria

[4] .

2.2.

Surgical technique

2.2.1.

Preoperative preparation and positioning

Patients do not undergo bowel preparation. Heparin prophylaxis is

administered within 1 h before incision. The patient is positioned supine

in a slightly hyperextended position.

2.2.2.

Incision and separation of the peritoneum

A midline abdominal incision is made

( Fig. 1 A

) from several centimeters

below the xiphoid process (approximating the level of the renal hilum)

to 4–5 cmbelow the umbilicus (approximating the level of the ipsilateral

common iliac artery).

Beginning in the infraumbilical portion of the incision, where

separation of the peritoneum from the fascia is easier, the anterior and

posterior rectus fascias are incised

( Fig. 1 B

), and the extraperitoneal

space between the peritoneum and the transversalis fascia is developed

with gentle blunt and sharp dissection.

The peritoneal sac is swept medially off the inferolateral abdominal

wall on the ipsilateral side of the planned dissection, aiming towards the

ipsilateral psoas muscle

( Fig. 1 D

).

Care is taken to avoid inadvertent opening of the peritoneum,

especially anteriorly where it becomes thin. Fibrous strands between the

peritoneum and abdominal wall can be taken down sharply to help

prevent tearing of the peritoneum.

2.2.3.

Entering the retroperitoneal space

As the peritoneal envelope is peeled off the posterior muscles in the

lower quadrant, retroperitoneal fat will be encountered. The edge of the

sac is peeled back from this and confirmed by visualization of the psoas

muscle

( Fig. 1

D).

2.2.4.

Ureteral identification

The ureter and gonadal vessels are visualized along the psoas

( Fig. 2

A),

and this plane is traced superiorly. The sac is separated from the

posterior ribs and then mobilized medially off of Gerota’s fascia.

Often some part of the fat of Gerota’s fascia will be medialized with

the peritoneum, which can be helpful in avoiding entering the sac, and

allows exposure to the renal parenchyma, which aids in ruling out

vascular compromise of the kidney during the case. Of note, the

attachments of the sac just below the liver (right-sided template) and

just below the spleen (left-sided template) can be quite fibrous, and

great care should be taken to avoid peritoneotomy in these difficult-to-

repair areas. Completely freeing the upper pole of the kidney off of the

overlying peritoneum is the safest way to accomplish this

( Fig. 2

B).

2.2.5.

Visualization of the great vessels

In the post-chemotherapy setting, ipsilateral residual masses are often

readily visible or palpable at this point. The peritoneal sac at this point is

typically easy to medialize further, stopping once the contralateral renal

hilum is reached. A self-retaining retractor is placed to retract the

abdominal wall and the peritoneal sac

( Fig. 2 C

).

Table 1 – Demographic data and perioperative outcomes

Parameter (

n

= 68)

Result

Age (yr)

28 (17–55)

Follow-up (mo)

15.3 (5.7–24.3)

Extraperitoneal retroperitoneal lymph node dissection 68/69 (98.6)

Primary

27 (39.7)

Nonseminomatous germ cell tumor

27 (100)

Stage I

7 (25.9)

Stage IIA

17 (63)

Stage IIB

1 (3.7)

Stage IIC

2 (7.4)

Post-chemotherapy

41 (60.3)

Nonseminomatous germ cell tumor

37 (90.2)

Seminomatous germ cell tumor

4 (9.8)

Retroperitoneal mass or lymphadenopathy on

preoperative imaging (cm)

2.2 (1.3–5.5)

0 cm

6 (8.9)

<

2 cm

23 (33.8)

2–4.9 cm

15 (22.1)

5–10 cm

5 (7.6)

>

10 cm

19 (27.9)

Intraoperative outcomes

Estimated blood loss (ml)

325 (200–612.5)

Packed red blood cells transfused (units)

0 (0–7)

a

Lymph node yield (

n

)

36 (24.5–49)

Positive lymph nodes (

n

)

1 (0–4)

Postoperative outcomes

Return of bowel function (d)

2 (1–2)

a

Length of stay (d)

3 (3–4)

a

Data are presented as median (interquartile range) for continuous

variables and as

n

(%) for continuous variables.

a

Range.

E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 8 1 4 – 8 2 0

815